ATE111734T1 - Verfahren zur herstellung von direktkomprimierten, cephalosporansäure derivate enthaltendentabletten. - Google Patents

Verfahren zur herstellung von direktkomprimierten, cephalosporansäure derivate enthaltendentabletten.

Info

Publication number
ATE111734T1
ATE111734T1 AT91920476T AT91920476T ATE111734T1 AT E111734 T1 ATE111734 T1 AT E111734T1 AT 91920476 T AT91920476 T AT 91920476T AT 91920476 T AT91920476 T AT 91920476T AT E111734 T1 ATE111734 T1 AT E111734T1
Authority
AT
Austria
Prior art keywords
manufacture
direct
acid derivatives
tablets containing
compressed tablets
Prior art date
Application number
AT91920476T
Other languages
English (en)
Inventor
Jean-Louis Laly
Roberto Lombardi
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Application granted granted Critical
Publication of ATE111734T1 publication Critical patent/ATE111734T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
AT91920476T 1990-11-15 1991-11-08 Verfahren zur herstellung von direktkomprimierten, cephalosporansäure derivate enthaltendentabletten. ATE111734T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9014210A FR2669221B1 (fr) 1990-11-15 1990-11-15 Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.

Publications (1)

Publication Number Publication Date
ATE111734T1 true ATE111734T1 (de) 1994-10-15

Family

ID=9402216

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91920476T ATE111734T1 (de) 1990-11-15 1991-11-08 Verfahren zur herstellung von direktkomprimierten, cephalosporansäure derivate enthaltendentabletten.

Country Status (11)

Country Link
US (1) US5514383A (de)
EP (1) EP0557389B1 (de)
JP (1) JP3253074B2 (de)
KR (1) KR100226386B1 (de)
AT (1) ATE111734T1 (de)
CA (1) CA2094122C (de)
DE (1) DE69104220T2 (de)
DK (1) DK0557389T3 (de)
ES (1) ES2060417T3 (de)
FR (1) FR2669221B1 (de)
WO (1) WO1992008463A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
PT800384E (pt) * 1994-12-14 2001-06-29 Enbalt Trading Ltd Metodo para a preparacao de um comprimido farmaceutico
ATE287218T1 (de) * 1996-02-29 2005-02-15 Fujisawa Pharmaceutical Co Schnellzerfallendes granulate von einem synthetischen süssstoff enthaltend kieselsäure und/oder siliciumdioxid
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US5735891A (en) * 1996-12-02 1998-04-07 Sulzer Intermedics Inc. Self-clamping anchoring sleeve
WO2000025751A2 (en) * 1998-10-30 2000-05-11 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
KR20030078105A (ko) * 2002-03-28 2003-10-08 (주)다산메디켐 제약 및 식품산업의 정제 제조시 반드시 거쳐야 하는공정인 타정(정제의 제조) 공정에서 타정을 위한 분체혼합물의 유동성을 개선하고 타정 공정시 발생되는타정장애 중 특히 타정물이 타정기 또는 타정펀치에 붙든현상인 점착성 발생을 없앤 제약산업에서 사용될 수 있는고형제제를 위한 직타용 부형제의 새로운 조성물에관한것이다.
US7803402B2 (en) * 2002-07-06 2010-09-28 Sanjeev Khandelwal Pharmaceutical preparations
JP2007536378A (ja) * 2004-05-10 2007-12-13 ルピン・リミテッド 生体利用性が強化されている新規セフィキシム医薬製剤
CN110041346B (zh) * 2019-04-17 2022-06-07 广东立国制药有限公司 一种低成本的头孢克肟的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208171A1 (es) * 1972-09-29 1976-12-09 Ciba Geigy Ag Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico
US4708956A (en) * 1985-12-12 1987-11-24 Kyowa Hakko Kogyo Co., Ltd. 3-position halogenated cephalosporin analogs and pharmaceutical compositions
JPH01149728A (ja) * 1987-12-04 1989-06-12 Fujisawa Pharmaceut Co Ltd 抗潰瘍剤
JPH01242589A (ja) * 1988-03-22 1989-09-27 Fujisawa Pharmaceut Co Ltd セフエム化合物
IL94946A0 (en) * 1989-07-13 1991-06-10 Eisai Co Ltd 3-substituted vinyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA2094122A1 (fr) 1992-05-16
JP3253074B2 (ja) 2002-02-04
DK0557389T3 (da) 1994-10-17
EP0557389B1 (de) 1994-09-21
US5514383A (en) 1996-05-07
KR100226386B1 (ko) 1999-10-15
EP0557389A1 (de) 1993-09-01
KR930702004A (ko) 1993-09-08
JPH06502420A (ja) 1994-03-17
FR2669221A1 (fr) 1992-05-22
FR2669221B1 (fr) 1993-01-15
DE69104220D1 (de) 1994-10-27
WO1992008463A1 (fr) 1992-05-29
DE69104220T2 (de) 1995-01-26
CA2094122C (fr) 2004-07-20
ES2060417T3 (es) 1994-11-16

Similar Documents

Publication Publication Date Title
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
UA19782A (uk) Спосіб одержаhhя біциклічhих складhих ефірів або їх фармацевтичhо прийhятhих солей
HUP9802517A2 (hu) Foszfonsavval helyettesített benzazepinon-N-ecetsav-származékok, eljárás ezek előállítására és az e vegyületeket tartalmazó gyógyászati készítmények
ES8407471A1 (es) Procedimiento para preparar derivados de prolina disustituidos
ATE111734T1 (de) Verfahren zur herstellung von direktkomprimierten, cephalosporansäure derivate enthaltendentabletten.
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
DE59106966D1 (de) Verfahren zur Herstellung von 3-Amino-2-(het)aroyl-acrylsäurederivaten.
DK0625153T3 (da) Nyt isoindolinonderivat, dets fremstilling og farmaceutiske præparater med et indhold deraf
DE59204049D1 (de) Verfahren zur Herstellung von Hydroxylammoniumsalzen.
DE59103466D1 (de) Verfahren zur Herstellung von Alkylydroxyanilino-triazinthioderivaten.
DE59204060D1 (de) Verfahren zur Herstellung von 1-Fluor-cyclopropan-1-carbonsäure.
DE58909140D1 (de) Verwendung stabiler Oxapenem-3-carbonsäuren zur Herstellung Beta-Lactamase hemmender Arzneimittel.
DE59106850D1 (de) Verfahren zur Herstellung von Kaliummagnesium-L-ascorbat-2-phosphat.
DE59104571D1 (de) Verfahren zur Herstellung von Vinylphosphonsäurederivaten.
DE69200795D1 (de) Verfahren zur Herstellung von L-Prolinederivaten.
ATE69809T1 (de) Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten.
DE69106897D1 (de) Verfahren zur Herstellung von Haloketosäureabkömmlingen.
DE59204105D1 (de) Verfahren zur Herstellung von Difluorbenzaldehyden.
ATE12390T1 (de) Basisch substituierte anthranilsaeuren, verfahren zu ihrer herstellung und ihre verwendung.
DE59202472D1 (de) Verfahren zur Herstellung von Dialkylaminopropandiol.
ATE145647T1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
ATE66468T1 (de) Leukotrienantagonisten, verfahren zu ihrer herstellung und ihre anwendung zur behandlung von krankheiten.
DE59203532D1 (de) Verfahren zur Herstellung von Nitrophenyl-alkylethern.
DE68908681D1 (de) Verfahren zur Herstellung von feinpulvrigem beta-Sialon.
DE59407069D1 (de) Verfahren zur Herstellung von Alkalisalzen des Cyanacetons

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time